INC01 IL-23 Innovation: New Data Addressing Plaque Psoriasis
DESCRIPTION
Join us for an engaging and compelling program exploring innovations in targeting the IL-23 pathway and new data shaping the treatment of plaque psoriasis. This session will review the science behind IL-23–targeted therapies and their role in addressing unmet needs across patient populations. Faculty will discuss select safety and efficacy data and potential impact on clinical decision-making as well as offer practical perspectives on treatment selection and prescribing considerations in today’s evolving plaque psoriasis landscape.
Speakers:
Bruce Strober, MD, PhD
April W. Armstrong, MD, MPH
Jason Hawkes, MD, MS
G. Michael Lewitt, MD
6:30 PM Registration | 7:00 PM - 9:00 PM PROGRAM
Registration link: https://forms.office.com/pages/responsepage.aspx?id=XCxh-ZiFl0isR4SoAI9UiGJiyBun2ZpFuVqAOEz2QOhUMTNNRFRCTkdMRE85MkZTUk45VzZITFdORC4u&route=shorturl
Where: Crystal Ballroom - Embassy Suites Denver Convention Center
Presented by: Johnson and Johnson
Save this program to your schedule in the AAD Meeting App!